FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a therapeutic agent for preventing and treating chronic liver diseases. The above agent represents amaranth oil prepared by cold pressing of amaranth seed kernels and coats, to be used in a dose of 62.5 - 250 mg/kg of body weight.
EFFECT: declared invention provides higher positive effect on biochemical processes in blood and liver tissues in treating toxic hepatitis.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR BODY MICROCIRCULATORY PROCESSES IMPROVEMENT AND METHOD FOR ITS APPLICATION | 2015 |
|
RU2646463C2 |
METHOD FOR CORRECTION OF ISONIAZID-INDUCED HEPATOTOXIC REACTIONS | 2015 |
|
RU2601919C1 |
METHOD FOR PREVENTING BIOLOGICAL MEMBRANE DAMAGES | 2013 |
|
RU2549449C2 |
METHOD FOR PREVENTION OF COMPLICATIONS INDUCED BY ISONIAZID | 2015 |
|
RU2597788C1 |
MEMBRANE-PROTECTIVE PREPARATION | 2013 |
|
RU2538803C1 |
"MOLODETSKOYE" OIL COMPOSITION AND ITS PRODUCTION METHOD | 2005 |
|
RU2374858C2 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
METHOD OF ENHANCEMENT OF RESISTANCE TO ERYTHROCYTE HEMOLYSIS AND RECOVERY OF THEIR DAMAGED FORM | 1998 |
|
RU2162698C2 |
2-AMINO-4-ACETYL-7-BROMO-8-HYDROXY-3,8-DIHYDROTHIAZOLO[5,4-b]INDOLE HYDROBROMIDE PROTECTING BODY AGAINST HYPOXIA AND LIVER AGAINST POISONING WITH CARBON TETRACHLORIDE | 2004 |
|
RU2281949C2 |
AN AQUEOUS SOLUTION SHOWING HEPATOPROTECTIVE EFFECT | 1996 |
|
RU2111746C1 |
Authors
Dates
2014-08-20—Published
2012-02-10—Filed